• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GIVEN IMAGING LTD., YOQNEAM JA PILLCAM SB3 CAPSULE; GASTROINTESTINAL MOTILITY SYSTEM, CAPSULE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GIVEN IMAGING LTD., YOQNEAM JA PILLCAM SB3 CAPSULE; GASTROINTESTINAL MOTILITY SYSTEM, CAPSULE Back to Search Results
Model Number FGS-0391-J
Device Problem Entrapment of Device (1212)
Patient Problem Foreign Body In Patient (2687)
Event Date 04/14/2022
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, the patient received a capsule procedure for a clone procedure in (b)(6) 2020.Two years have passed without confirming the external discharge.When the patient visited the hospital again due to worsening of the underlying disease, a capsule remaining in the ileum terminal was discovered.A small intestine resection was performed on (b)(6) 2022 as a measure to treat the worsening of the underlying disease, at that time, the relevant capsule was also collected.The physician requested that the device be checked to see whether or not there is a component dropout from the capsule or a battery solution leak.
 
Manufacturer Narrative
Additional information: b5, g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.The evaluation found no potentially contributing factors, and the sample met all related specifications.It was reported that the capsule remained in the patient longer than expected.The reported issue could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, the patient received a capsule procedure for a clone procedure in april 2020.Two years have passed without confirming the external discharge.When the patient visited the hospital again due to worsening of the underlying disease, a capsule remaining in the ileum terminal was discovered.A small intestine resection was performed on (b)(6) 2022 as a measure to treat the worsening of the underlying disease.At that time, the relevant capsule was also collected.The physician requested that the device be checked to see whether or not there was a component dropout from the capsule or a battery solution leak.The patient did not take any patency capsule.There was only one capsule retrieved from the patient.There was no patient or user harm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JA PILLCAM SB3 CAPSULE
Type of Device
GASTROINTESTINAL MOTILITY SYSTEM, CAPSULE
Manufacturer (Section D)
GIVEN IMAGING LTD., YOQNEAM
yetsira 13 street
yoqneam 20692
IS  20692
Manufacturer (Section G)
GIVEN IMAGING LTD., YOQNEAM
yetsira 13 street
yoqneam 20692
IS   20692
Manufacturer Contact
amy beeman
161 cheshire lane, suite 100
plymouth, MN 55441
7632104064
MDR Report Key14278993
MDR Text Key290651260
Report Number9710107-2022-00110
Device Sequence Number1
Product Code NYV
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFGS-0391-J
Device Catalogue NumberFGS-0391-J
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/19/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/15/2022
Initial Date FDA Received05/04/2022
Supplement Dates Manufacturer Received06/13/2022
Supplement Dates FDA Received06/27/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-